Testing new mRNA flu vaccines for safety and immune response
Part of Infections, Lungs & breathing clinical trials.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 59 years old.
- You must not be pregnant or breastfeeding, and must use contraception if you could become pregnant.
- You must be in generally good health, with any chronic conditions (like high blood pressure or diabetes) stable for at least 60 days.
- You must not have a history of heart inflammation, Guillain-Barré syndrome, or a weakened immune system.
- You must not have had a flu vaccine or flu infection in the last 90 days.
- You must be willing to give blood samples and follow the study schedule for about 10 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.